Stefanie is an expert in all regulatory, commercial and contractual matters in the pharmaceutical, medical device and biotech sector as well as in compliance-relevant topics in this area. She advises on the drafting and negotiation of complex and cross-border licensing agreements (out-licensing and in-licensing), research and development collaborations, manufacturing and distribution agreements as well as clinical trial agreements and with CROs.

In M&A and private equity transactions in the life sciences sector, she advises on all regulatory and contractual issues.

显示完整简历 隐藏完整简历

最新新闻和观点

医疗器械

Medical devices in the context of the European Commission's AI Regulation draft

2023年9月18日
Briefing

作者 Sherin Sayed 以及 Dr. Stefanie Greifeneder

点击此处了解更多
酒店与休闲

Draft of a cannabis law for the further legalisation of cannabis in Germany

2023年9月27日

作者 Dr. Daniel Tietjen 以及 Ennio Schwind, LL.M. Eur.

点击此处了解更多
酒店与休闲

Legal requirements for green claims in advertising for medical devices

2023年9月27日
Briefing

作者 Dr. Daniel Tietjen 以及 Sherin Sayed

点击此处了解更多
专利与创新

Patenting AI-generated inventions – is patent law acting the luddite?

2023年9月21日
Briefing

作者 Dr. Nora E. Wessendorf, LL.M. (Washington)

点击此处了解更多

与我会面:

11月21日

11:00 - 11:45

网络研讨会

Medical devices & the EU draft regulation on AI – new challenges for my business?

更多